Genomic Vision: Ayoub Kriem exceeds 5% of capital and voting rights
June 26, 2023 at 10:52 am EDT
On June 22, 2023, Ayoub Kriem declared that he had exceeded, directly and indirectly via Winsalus LLC, a company he controls, the thresholds of 5% of the capital and voting rights of Genomic Vision, and that he directly and indirectly held 8.59% of the company's capital and voting rights.
This crossing of thresholds results from the conversion of 'OCA' convertible bonds into shares.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Legal disclaimer
Legal disclaimer
Contact us to request a correction